Abstract
The knowledge base required to diagnose and treat cardiovascular disease (CVD) is large and rapidly expanding, although the amount of time available to physicians and other health care providers to acquire this information is finite and shrinking. As clinicians, we are required to triage new information with respect to its importance and value to our clinical mission and to the time and effort required to learn and incorporate it into our practices. Thus, three important questions to address at the beginning of this book are: (1) “Why do I need to know about complimentary and alternative medicine (CAM)?” (2) “What do 1 need to know about CAM and CVD?” and (3) How do I assess multiple reports and studies on CAM and CVD for best evidence to provide effective and sensitive patient counseling?
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Eisenberg DM, Kestrel RCA, Foster C, Norlick FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States: prevalence, costs, and patterns of use. N Engl J Med 1993; 328: 246–252.
Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990–1997: Results of a follow-up national survey. JAMA 1998; 280: 1569–1575.
Wootton JC, Sparber A. Surveys of complementary and alternative medicine: Part. general trends and demographic groups. J Altern Complement Med 2001; 7: 195–208.
Landmark Health Care. The Landmark Report on Public Perceptions of Alternative Care. Landmark Healthcare Inc., Sacramento, CA, 1998.
Astin JA. Why patients use alternative medicine: results of a national survey. JAMA 1998; 279: 1548–1553.
Paramore LC. Use of alternative therapies: estimates from the 1994 Robert Wood Johnson Foundation National Access to Care Survey. J Pain Symptom Manage 1997; 13: 83–89.
Liu EH, Turner LM, Lin SX, et al. Use of alternative medicine by patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 2000; 120: 335–341.
Blakely JA. The heart and estrogen/progestin replacement study revisited: hormone replacement therapy produced net harm, consistent with the observational data. Arch Intern Med 2000; 160: 2897–2900.
Adams KE, Cohen MH, Eisenberg D, Johnsen AR. Ethical considerations of complementary and alternative medical therapies in convention medical settings. Ann Intern Med 2002; 137: 660–664.
Weiger WA, Smith M, Boon H, Richardson MA, Kaptchuk TJ, Eisenberg DM. Advising patients who seek complementary and alternative medical therapies for cancer. Ann Intern Med 2002; 137: 889–903.
Hymes KB, Greene JB, Marcus A. Kaposi’ s sarcoma in homosexual men—a report of eight cases. Lancet 1981; 2: 598–602.
Clinical Practice Guideline Number 17: Cardiac Rehabilitation. US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, National Heart, Lung and Blood Institute. AHCPR Publication No. 96–0672. October 1995.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Stein, R.A., Oz, M.C. (2004). Complementary and Alternative Medicine in the Prevention and Treatment of Cardiovascular Disease. In: Stein, R.A., Oz, M.C. (eds) Complementary and Alternative Cardiovascular Medicine. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-728-4_1
Download citation
DOI: https://doi.org/10.1007/978-1-59259-728-4_1
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4684-9831-8
Online ISBN: 978-1-59259-728-4
eBook Packages: Springer Book Archive